| Revenue growth | Total revenue Rs13,630 Mn, +41.3% YoY |
|---|---|
| Margins | EBITDA margin 20.5%, down 110bps YoY, up 40bps QoQ |
| Demand visibility | IP volume +27.0% YoY; OP volume +23.3% YoY |
Growth
Q2 operating revenue +39.9% YoY; IP volume +27.0%, ARPOB +14.9%. H1 total revenue +38.8%, but H1 PAT -28.0% YoY.
Outlook
No quantified guidance given. Adds 700+ beds via greenfield, acquisitions and O&M; Chennai (300) and Rajahmundry II (350) beds planned.
Risks
EBITDA margin down 110bps YoY to 20.5%. Q2 PBT includes Rs132 Mn call option gain. Karnataka cluster still loss-making.
Investor Presentation filed with NSE, NSE: KIMS. Summary written with AI assistance from the document.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹745.35
- Market cap
- ₹31,305 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 153.2×Sector 53.8×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
Krishna Institute of Medical Sciences Management Change
KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.
- Execution
- 5 years
Krishna Institute of Medical Sciences Results Update
KIMS reported Q2 FY27 consolidated revenue of Rs 1,363 Crore, up 41.3% YoY, with PAT of Rs 76 Crore. EBITDA rose 34% YoY to Rs 279 Crore.
Krishna Institute of Medical Sciences Q2 FY27 Results: Net Profit ₹74.6 Cr, Up 3.6% YoY
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,344 Cr (+39.9% YoY) and net profit of ₹74.6 Cr (+3.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.6 Cr · +3.6% YoY
Krishna Institute of Medical Sciences Capacity Expansion
KIMS Saveera Hospital in Anantapur expanded from 250 to 500 beds, with new oncology and mother-and-child blocks inaugurated November 1, 2026. No monetary value disclosed.
- hospital beds
- 250.0 beds
Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr